Assessment of immunotoxicity parameters in individuals occupationally exposed to lead

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 75, Issue 13-15, 2012, Pages 807-818

  García Lestón, Julia ^a   Roma Torres, Joana ^b   Mayan, Olga ^b   Schroecksnadel, Sebastian ^c   Fuchs, Dietmar ^c   Moreira, Ana O ^b   Pásaro, Eduardo ^a   Méndez, Josefina ^a   Teixeira, João Paulo ^b   Laffon, Blanca ^a  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b NATIONAL INSTITUTE OF HEALTH   (Portugal)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; KYNURENINE; LEAD; NEOPTERIN; PORPHOBILINOGEN SYNTHASE; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR;

AGE; CONFERENCE PAPER; CONTROLLED STUDY; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; IMMUNOTOXICITY; LEAD BLOOD LEVEL; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING;

ADULT; BIOLOGICAL MARKERS; CYTOKINES; GENETIC ASSOCIATION STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDUSTRY; KYNURENINE; LEAD; LEAD POISONING; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; NEOPTERIN; OCCUPATIONAL EXPOSURE; POLYMORPHISM, GENETIC; PORPHOBILINOGEN SYNTHASE; PORTUGAL; RECEPTORS, CALCITRIOL; SMOKING; SPAIN; TRYPTOPHAN;

EID: 84864043342     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2012.690327     Document Type: Conference Paper

References (48)

1. Apostoli, P. 1998. Update on the subject of lead toxicology. Ann. Ist. Super Sanita, 34: 5-15.
2. Arnson, Y., Shoenfeld, Y., and, Amital, H. 2010. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J. Autoimmun., 34: J258-65.
3. Boscolo, P., Di Gioacchino, M., Sabbioni, E., Benvenuti, F., Conti, P., Reale, M., Bavazzano, P., and, Giuliano, G. 1999. Expression of lymphocyte subpopulations, cytokine serum levels, and blood and urinary trace elements in asymptomatic atopic men exposed to an urban environment. Int. Arch. Occup. Environ. Health., 72: 26-32.
4. Boscolo, P., Di Gioacchino, M., Sabbioni, E., Di Giacomo, F., Reale, M., Volpe, A. R., Di Sciascio, M.B., Conti, P., and, Giuliano, G. 2000. Lymphocyte subpopulations, cytokines and trace elements in asymptomatic atopic women exposed to an urban environment. Life Sci., 67: 1119-26.
5. Chen, S., Golemboski, K.A., Piepenbrink, M., and, Dietert, R.R. 2004. developmental immunotoxicity of lead in the rat: Influence of maternal diet. J. Toxicol. Environ. Health A, 67: 495-511.
6. Ciprandi, G., Amici, M., Tosca, M., and, Fuchs, D. 2010. Tryptophan metabolism in allergic rhinitis: The effect of pollen allergen exposure. Hum. Immunol., 71: 911-15.
7. Counter, S. A., Buchanan, L. H., and, Ortega, F. 2009. Neurocognitive screening of lead-exposed Andean adoplescents and young adults. J. Toxicol. Environ. Health A, 72: 625-32.
8. Diamondstone, L. S., Tollerud, D. J., Fuchs, D., Wachter, H., Brown, L. M., Maloney, E., Kurman, C. C., Nelson, D. L., and, Blattner, W. A. 1994. Factors influencing serum neopterin and beta 2-microglobulin levels in a healthy diverse population. J. Clin. Immunol., 14: 368-74.
9. Dietert, R. R., and, Piepenbrink, M. S. 2006. Lead and immune function. Crit. Rev. Toxicol., 36: 359-85.
10. Dyatlov, V. A., and, Lawrence, D. A. 2002. Neonatal lead exposure potentiates sickness behavior induced by Listeria monocytogenes infection of mice. Brain Behav. Immun., 16: 477-92.
11. Engin, A. B., Tuzun, D., and, Sahin, G. 2006. Evaluation of pteridine metabolism in battery workers chronically exposed to lead. Hum. Exp. Toxicol., 25: 353-59.
12. Falq, G., Zeghnoun, A., Pascal, M., Vernay, M., Le Strat, Y., Garnier, R., Olichon, D., Bretin, P., Castetbon, K., and, Frery, N. 2011. Blood lead levels in the adult population living in France the French Nutrition and Health Survey (ENNS 2006-2007). Environ. Int., 37: 565-71.
13. Fischbein, A., Tsang, P., Luo, J. C. J., Roboz, J. P., Jiang, J. D., and, Bekesi, J. G. 1993. Phenotypic aberrations of CD3+ and CD4+ cells and functional impairments of lymphocytes at low-level occupational exposure to lead. Clin. Immunol. Immunopathol., 66: 163-68.
14. Frick, B., Schroecksnadel, K., Neurauter, G., Leblhuber, F., and, Fuchs, D. 2004. Increasing production of homocysteine and neopterin and degradation of tryptophan with older age. Clin. Biochem., 37: 684-87.
15. García-Lestón, J., Roma-Torres, J., Vilares, M., Pinto, R., Cunha, L. M., Prista, J., Teixeira, J. P., Mayan, O., Pásaro, E., Méndez, J., and, Laffon, B. 2011. Biomonitoring of a population of Portuguese workers exposed to lead. Mutat. Res., 721: 81-88.
16. Gor, D. O., Rose, N. R., and, Greenspan, N. S. 2003. TH1-TH2: A procrustean paradigm. Nat. Immunol., 4: 503-5.
17. Heo, Y., Parsons, P. J., and, Lawrence, D. A. 1996. Lead differentially modifies cytokine production in vitro and in vivo. Toxicol. Appl. Pharmacol., 138: 149-57.
18. Heo, Y., Lee, W. T., and, Lawrence, D. A. 1997. In vivo the environmental pollutants lead and mercury induce oligoclonal T cell responses skewed toward type-2 reactivities. Cell Immunol., 179: 185-95.
19. International Agency for Research on Cancer. 1987. Lead and lead compounds, inorganic. IARC Monogr., 23 (suppl. 7)
20. International Agency for Research on Cancer. 2006. Inorganic and organic lead compounds. IARC Monogr. Eval. Carcinogen. Risks Hum., 87
21. Iavicoli, I., Carelli, G., Stanek, E. J. 3rd, Castellino, N., and, Calabrese, E. J. 2006. Below background levels of blood lead impact cytokine levels in male and female mice. Toxicol. Appl. Pharmacol., 210: 94-99.
22. Kaminska, T., Filar, J., Madej, E., Szuster-Ciesielska, A., and, Kandefer-Szerszen, M. 1998. Modification of bovine interferon and tumor necrosis factor production by lead in vivo and in vitro. Arch. Immunol. Ther. Exp., 46: 323-28.
23. Kerr, W. K., Barkin, M., Levers, P. E., Woo, S. K., and, Menczyk, Z. 1965. The effect of cigarette smoking on bladder carcinogens in man. Can. Med. Assoc. J., 93: 1-7.
24. Kositz, C., Schroecksnadel, K., Grander, G., Schennach, H., Kofler, H., and, Fuchs, D. 2008. Serum tryptophan concentration in patients predicts outcome of specific immunotherapy with pollen extracts. Int. Arch. Allergy Immunol., 147: 35-40.
25. Luebke, R. W., Chen, D. H., Dietert, R., Yang, Y., King, M., and, Luster, M. I. 2006. The comparative immunotoxicity of five selected compounds following developmental or adult exposure. J. Toxicol. Environ. Health B, 9: 1-26.
26. McCabe, M. J. Jr., and, Lawrence, D. A. 1991. Lead, a major environmental pollutant, is immunomodulatory by its differential effects on CD4+ T cells subsets. Toxicol. Appl. Pharmacol., 111: 13-23.
27. McCabe, M. J. Jr., Singh, K. P., and, Reiners, J. J. Jr. 1999. Lead intoxication impairs the generation of a delayed type hypersensitivity response. Toxicology, 139: 255-64.
28. high T cells. Toxicol. Appl. Pharmacol., 177: 219-31.
29. McNerlan, S. E., Rea, I. M., and, Alexander, H. D. 2002. A whole blood method for measurement of intracellular TNF-alpha, IFN-gamma and IL-2 expression in stimulated CD3+ lymphocytes: Differences between young and elderly subjects. Exp. Gerontol., 37: 227-34.
30. Mishra, K. P. 2009. Lead exposure and its impact on immune system: A review. Toxicol. In Vitro, 23: 969-72.
31. Mishra, K.P., Rani, R., Yadav, V. S., and, Naik, S. 2010. Effect of lead exposure on lymphocyte subsets and activation markers. Immunopharmacol. Immunotoxicol., 32: 446-49.
32. Pinkerton, L. E., Biagini, R. E., Ward, E. M., Hull, R. D., Deddens, J. A., Boeniger, M. F., Schnorr, T. M., MacKenzie, B. A., and, Luster, M. I. 1998. Immunologic findings among lead-exposed workers. Am. J. Ind. Med., 33: 400-8.
33. Rink, L., Cakman, I., and, Kirchner, H. 1998. Altered cytokine production in the elderly. Mech. Ageing Dev., 102: 199-209.
34. Ryter, S. W., and, Choi, A. M. 2010. Heme oxygenase-1/carbon monoxide: Novel therapeutic strategies in critical care medicine. Curr. Drug Targets., 11: 1485-94.
35. Sakai, T. 2000. Biomarkers of lead exposure. Ind. Health., 38: 127-42.
36. Sata, F., Araki, S., Tanigawa, T., Morita, Y., Sakurai, S., Nakata, A., and, Katsuno, N. 1998. Changes in T cell subpopulations in lead workers. Environ. Res., 76: 61-64.
37. Schennach, H., Murr, C., Gachter, E., Mayersbach, P., Schonitzer, D., and, Fuchs, D. 2002. Factors influencing serum neopterin concentrations in a population of blood donors. Clin. Chem., 48: 643-45.
38. Schindowski, K., Frohlich, L., Maurer, K., Muller, W. E., and, Eckert, A. 2002. Age-related impairment of human T lymphocytes activation: specific differences between CD4(+) and CD8(+) subsets. Mech. Ageing Dev., 123: 375-90.
39. Schroecksnadel, S., Jenny, M., Kurz, K., Klein, A., Ledochowski, M., Uberall, F., and, Fuchs, D. 2010. LPS-induced NF-kappaB expression in THP-1Blue cells correlates with neopterin production and activity of indoleamine 2,3-dioxygenase. Biochem. Biophys. Res. Commun., 399: 642-46.
40. Shaik, A. P., and, Jamil, K. 2008. A study on the ALAD gene polymorphisms associated with lead exposure. Toxicol. Ind. Health., 24: 501-6.
41. Spencer, M. E., Jain, A., Matteini, A., Beamer, B. A., Wang, N. Y., Leng, S. X., Punjabi, N. M., Walston, J. D., and, Fedarko, N. S. 2010. Serum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI, and percentage of body fat. J. Gerontol. A Biol. Sci. Med. Sci., 65: 858-65.
42. Taylor, M. W., and, Feng, G. S. 1991. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J., 5: 2516-22.
43. Uitterlinden, A. G., Fang, Y., van Meurs, J. B., van Leeuwen, H., and, Pols, H. A. 2004. Vitamin D receptor gene polymorphisms in relation to vitamin D related disease states. J. Steroid Biochem. Mol. Biol. 89-, 90: 187-93.
44. Walter, R. B., Fuchs, D., Weiss, G., Walter, T. R., and, Reinhart, W. H. 2003. HMG-CoA reductase inhibitors are associated with decreased serum neopterin levels in stable coronary artery disease. Clin. Chem. Lab. Med., 41: 1314-19.
45. Widner, B., Laich, A., Sperner-Unterweger, B., Ledochowski, M., and, Fuchs, D. 2002. Neopterin production, tryptophan degradation, and mental depressionWhat is the link?. Brain Behav. Immun., 16: 590-95.
46. Widner, B., Werner, E. R., Schennach, H., Wachter, H., and, Fuchs, D. 1997. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin. Chem., 43: 2424-26.
47. Wu, W. T., Tsai, P. J., Yang, Y. H., Yang, C. Y., Cheng, K. F., and, Wu, T. N. 2011. Health impacts associated with the implementation of a national petrol-lead phase-out program (PLPOP): Evidence from Taiwan between 1981 and 2007. Sci. Total Environ., 409: 863-867.
48. Ye, X.-B., Fu, H., Zhu, J.-J., Ni, W.-M., Lu, Y.-W., Kuang, X.-Y., Yang, S.-L., and, Shu, B.-X. 1999. A study on oxidative stress in lead-exposed workers. J. Toxicol. Environ. Health A, 56: 161-72.